Updfasp. z o.o.

Research and experimental development in natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-06-30
Share capital
20,000.00 PLN
Registered address
Rondo Ignacego Daszyńskiego 1, 00-843 Warszawa, Poland
Electronic delivery address
AE:PL-58426-27127-EAEIJ-18

Financials

From the notes

Loans and borrowings$80,684

Filing timeliness

The financial statement for 2025 was filed on time.

  • 202510/07/2026
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 0.09MedianUSD 152.85kAverageUSD 4.86m
Net profit
This companyUSD -5.07kMedianUSD -228.23AverageUSD 317.06k
Operating costs
This companyUSD 4.36kMedianUSD 187.91kAverageUSD 4.67m
Assets
This companyUSD 94.23kMedianUSD 278.35kAverageUSD 8.47m

Authorized Representatives

Jan Szczerbaniewicz – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Błażej Stanisław Szczerbaniewiczage 55
330$4,457.0582.5%
70$945.4317.5%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2025-07-25.

  • mBank
    26 1140 2062 0000 7585 6400 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$53,733

Competitors

Name
Oasis DiagnosticsS.A.
NanosanguisS.A.
Codeit4us Rndsp. z o.o.
VB IdeaP.S.A.
NanovelosS.A.
Bio2materialssp. z o.o.
Nanostalsp. z o.o.
IncellvuS.A.
NanotheaS.A.
MolecureS.A.

FAQ

Last updated: 2026-10-04